UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13D
Under the Securities Exchange Act of 1934
Amendment No.: 1
Name of Issuer: ELXSI Corporation
Title of Class of Securities: Common Stock
CUSIP Number: 268-613-106
(Name, Address and Telephone Number of Person
Authorized To Receive Notices and Communications)
Sven B. Karlen, Jr., Grandview Partners, L.P., Two International
Place, 24th Floor, Boston, MA 02110 (617) 856-8877
(Date of Event which Requires Filing of this Statement)
October 1, 1998
If the filing person has previously filed a statement on Schedule
13G to report the acquisition which is the subject of this
Schedule 13D, and is filing this schedule because of
Rule 13d-1(b)(3) or (4), check the following box [ ].
Note: Six copies of this statement, including all exhibits,
should be filed with the Commission. See rule 13d-1(a) for other
parties to whom copies are to be sent.
* The remainder of this cover page shall be filled out for a
reporting person's initial filing on this form with respect to
the subject class of securities, and for any subsequent amendment
containing information which would alter the disclosures provided
in a prior cover page.
The information required in the remainder of this cover page
shall not be deemed to be "filed" for the purpose of Section 18
of the Securities Exchange Act of 1934 ("Act") or otherwise
subject to the liabilities of that section of the Act but shall
be subject to all other provisions of the Act (however, see the
Notes).
<PAGE>
CUSIP No. 268-613-106
1. Name of Reporting Person
I.R.S. Identification No. of Above Person
Sven B. Karlen, Jr.
2. Check the Appropriate Box if a Member of a Group
a.
b.
3. SEC Use Only
4. Source of Funds
AF
5. Check if Disclosure of Legal Proceedings is Required Pursuant
to Items 2(d) or 2(e)
6. Citizenship or Place of Organization
USA
Number of Shares Beneficially Owned by Each Reporting Person
with:
7. Sole Voting Power:
8. Shared Voting Power:
2,500
9. Sole Dispositive Power:
10. Shared Dispositive Power:
2,500
11. Aggregate Amount Beneficially Owned by Each Reporting Person
2,500
12. Check Box if the Aggregate Amount in Row (11) Excludes
Certain Shares
2
<PAGE>
13. Percent of Class Represented by Amount in Row (11)
0.1%
14. Type of Reporting Person
IN
3
<PAGE>
CUSIP No. 268-613-106
1. Name of Reporting Person
I.R.S. Identification No. of Above Person
Grandview Partners, L.P.
2. Check the Appropriate Box if a Member of a Group
a.
b.
3. SEC Use Only
4. Source of Funds
WC
5. Check if Disclosure of Legal Proceedings is Required Pursuant
to Items 2(d) or 2(e)
6. Citizenship or Place of Organization
New York
Number of Shares Beneficially Owned by Each Reporting Person
with:
7. Sole Voting Power:
8. Shared Voting Power:
2,500
9. Sole Dispositive Power:
10. Shared Dispositive Power:
2,500
11. Aggregate Amount Beneficially Owned by Each Reporting Person
2,500
12. Check Box if the Aggregate Amount in Row (11) Excludes
Certain Shares
4
<PAGE>
13. Percent of Class Represented by Amount in Row (11)
0.1%
14. Type of Reporting Person
PN
5
<PAGE>
The purpose of this Amendment No. 1 to the previously
filed Schedule 13D is to report that Grandview Partners,
L.P. (the "Partnership") and Sven B. Karlen, Jr.
(together, the "Reporting Persons") are no longer
greater than five percent beneficial owners in the
common stock (the "Shares") of ELXSI Corporation (the
"Issuer").
Item 1. Security and Issuer
No change.
Item 2. Identity and Background
This statement is being filed on behalf of the
Partnership and Mr. Karlen. Mr. Karlen is the sole
general partner of the Partnership, is the sole managing
general partner of Svenvest Partners, L.P. and exercises
investment discretion over a managed account. The
address of the Partnership and Mr. Karlen is Two
International Place, 24th Floor, Boston, Massachusetts,
02110.
Neither of the Reporting Persons has, during the last
five years, been convicted in a criminal proceeding.
Neither of the Reporting Persons has, during the last
five years, been a party to a civil proceeding of a
judicial or administrative body of competent
jurisdiction which resulted in a judgment, decree or
final order enjoying future violations of, or
prohibiting or mandating activities subject to, federal
or state securities laws or finding any violations with
respect to such laws.
Mr. Karlen is a citizen of the United States of America.
Grandview Partners, L.P. is a New York limited
partnership.
Item 3. Source and Amount of Funds or Other Consideration
As of the date hereof, the Partnership owns and Mr.
Karlen is deemed to beneficially own 2,500 Shares. All
of the Shares were purchased in open market transactions
for an aggregate purchase price of $25,938. The funds
for the purchase of the Shares held by the Partnership
have come from the working capital of the Partnership.
No funds were borrowed to purchase any of the Shares.
6
<PAGE>
Item 4. Purpose of Transaction
No change.
Item 5. Interest in Securities of the Issuer
As of the date hereof, the Partnership owns 2,500
Shares. Based on the Issuer's filing on Form 10-Q on
August 12, 1998, as of July 30, 1998, there were
4,569,259 Shares outstanding. Therefore, the
Partnership owns and Mr. Karlen is deemed to
beneficially own 0.1% of the outstanding Shares. The
Reporting Persons have the shared power to vote, direct
the vote, dispose of or direct the disposition of all
the Shares that they are deemed to beneficially own.
All transactions in the Shares effected by the Reporting
Persons since the last filing on Schedule 13D were
effected in open-market transactions and are set forth
in Exhibit B hereto.
As of October 1, 1998, the Reporting Persons were no
longer greater than five percent beneficial owners of
the Shares. The Reporting Persons inadvertently did not
file prior amendments to Schedule 13D. The transactions
effected since the last Schedule 13D filing are listed
herein as Exhibit B.
Item 6. Contracts, Arrangements, Understandings or
Relationships with Respect to Securities of
the Issuer
No change.
Item 7. Material to be Filed as Exhibits
1. An agreement relating to the filing of a joint
statement as required by Rule 13D-1(f) under the
Securities Exchange Act of 1934 is filed herewith
as Exhibit A.
2. Attached hereto as Exhibit B is a description of
the transactions in the Shares that were effected
by the Reporting Person from January 20, 1995, but
were inadvertently unreported through the date of
this filing.
7
<PAGE>
Signature
After reasonable inquiry and to the best of my knowledge
and belief, I certify that the information set forth in this
statement is true, complete and correct.
GRANDVIEW PARTNERS, L.P.
By: /s/ Sven B. Karlen, Jr.
Sven B. Karlen, Jr.
General Partner
/s/ Sven B. Karlen, Jr.
Sven B. Karlen, Jr.
November 19, 1998
8
00188001.AG5
<PAGE>
Exhibit A
AGREEMENT
The undersigned agree that this Schedule 13D dated
November 19, 1998 relating to the Common Stock of ELXSI
Corporation shall be filed on behalf of the undersigned.
GRANDVIEW PARTNERS, L.P.
By: /s/ Sven B. Karlen, Jr.
Sven B. Karlen, Jr.
General Partner
/s/ Sven B. Karlen, Jr.
Sven B. Karlen, Jr.
9
00188001.AG5
<PAGE>
EXHIBIT B
SCHEDULE OF TRANSACTIONS
Price Per Share
(Excluding
Date Shares Acquired Commission)
____ (Sold)
1/20/95 5,000 $5.750
6/26/95 2,500 6.000
8/31/95 500 7.250
12/29/95 1,000 6.1250
1/31/96 (40,000) 6.000
1/31/96 (10,000) 6.000
1/31/96 13,000 6.040
1/31/96 32,000 6.0807
1/31/96 5,000 6.040
2/5/96 2,000 6.5305
2/6/96 2,000 6.430
2/7/96 5,000 10.700
3/29/96 1,000 6.500
5/24/96 5,000 6.875
7/31/96 2,000 5.5185
8/9/96 1,000 5.2576
8/19/96 2,000 5.2654
8/20/96 5,000 5.2530
9/30/96 1,000 5.500
10/16/96 3,000 5.125
10/22/96 10,000 5.125
10
00188001.AG5
<PAGE>
SCHEDULE OF TRANSACTIONS
Price Per Share
(Excluding
Date Shares Acquired Commission)
____ (Sold)
10/31/96 5,000 $5.125
11/4/96 5,000 5.125
11/6/96 3,000 5.125
11/7/96 13,000 5.041
11/7/96 2,000 5.041
11/13/96 2,500 5.125
11/18/96 2,500 5.500
11/19/96 5,000 5.3125
11/21/96 (18,500) 5.250
11/21/96 (61,500) 5.250
11/22/96 5,000 5.250
12/3/96 5,000 5.250
12/5/96 5,000 5.500
12/6/96 5,000 5.250
12/12/96 (58,500) 5.500
12/12/96 40,000 5.500
12/13/96 40,000 5.500
12/16/96 (60,000) 5.3750
12/16/96 (40,000) 5.5000
12/16/96 60,000 5.375
12/17/96 12,000 5.250
11
00188001.AG5
<PAGE>
SCHEDULE OF TRANSACTIONS
Price Per Share
(Excluding
Date Shares Acquired Commission)
____ (Sold)
12/18/96 1,000 $5.8729
12/23/96 (22,000) 5.3750
12/31/96 2,500 6.6250
12/31/96 1,000 6.6825
1/2/97 6,500 6.500
1/29/97 5,000 10.450
1/31/97 1,000 6.750
2/11/97 (10,000) 12.5632
2/12/97 10,000 6.3750
3/3/97 (20,000) 6.3750
3/4/97 10,000 6.8750
3/5/97 (10,000) 6.8750
3/31/97 1,000 6.750
4/21/97 2,000 6.375
4/21/97 5,000 6.375
4/22/97 5,000 6.375
4/29/97 1,000 6.350
5/21/97 2,500 6.250
5/23/97 2,000 6.500
6/2/97 2,500 6.625
6/2/97 2,000 6.750
6/9/97 2,000 7.375
12
00188001.AG5
<PAGE>
SCHEDULE OF TRANSACTIONS
Price Per Share
(Excluding
Date Shares Acquired Commission)
____ (Sold)
6/10/97 (16,000) $6.6250
6/18/97 2,500 7.1250
6/19/97 5,000 7.1250
6/20/97 (2,500) 7.2500
6/23/97 5,000 7.1250
6/25/97 (10,000) 7.1250
6/27/97 2,500 7.125
6/30/97 2,500 7.250
7/7/97 (2,500) 7.000
7/21/97 7,500 7.375
7/24/97 (2,500) 7.2500
7/30/97 2,500 7.3750
8/4/97 (7,500) 7.3750
8/7/97 2,500 7.6250
8/8/97 15,000 8.0708
8/12/97 (2,500) 7.5000
9/16/97 (43,700) 11.5143
9/17/97 (6,300) 11.6984
10/8/97 2,500 9.375
10/9/97 2,500 9.750
10/9/97 2,000 10.250
13
00188001.AG5
<PAGE>
SCHEDULE OF TRANSACTIONS
Price Per Share
(Excluding
Date Shares Acquired Commission)
____ (Sold)
10/31/97 9,000 $9.875
12/9/97 10,000 12.750
12/31/97 (20,000) 11.4225
12/31/97 20,000 11.4525
1/14/98 5,000 11.250
3/13/98 (3,000) 16.700
3/16/98 (17,000) 16.700
3/17/98 (3,000) 16.700
3/18/98 3,000 13.750
3/20/98 4,000 13.750
3/23/98 8,000 13.750
3/26/98 1,000 13.500
3/27/98 2,500 14.000
4/7/98 5,000 13.500
4/13/98 3,500 12.625
5/29/98 2,500 12.625
6/1/98 1,000 12.500
7/6/98 1,000 11.500
7/10/98 100 12.500
9/16/98 (50,000) 9.8125
10/1/98 (44,000) 9.3500
14
00188001.AG5
<PAGE>
SCHEDULE OF TRANSACTIONS
Price Per Share
(Excluding
Date Shares Acquired Commission)
____ (Sold)
10/1/98 (206,000) $9.500
10/9/98 (105,100) 9.500
10/14/98 (44,500) 9.000
15
00188001.AG5